
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study
Chan, John K., Deng, Wei, Higgins, Robert V., Tewari, Krishnansu S., Bonebrake, Albert J., Hicks, Michael, Gaillard, Stephanie, Ramirez, Pedro T., Chafe, Weldon, Monk, Bradley J., Aghajanian, CarolLangue:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.05.033
Date:
July, 2017
Fichier:
PDF, 439 KB
english, 2017